HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers

AIDS

Volumn 13, Issue 1, 1999, Pages 23-29

  Kaul, Rupert ^b,d   Trabattoni, Daria ^c   Bwayo, Job J ^a   Arienti, Donatella ^c   Zagliani, Arianna ^c   Mwangi, Francis M ^a   Kariuki, Cecilia ^a   Ngugi, Elizabeth N ^a   MacDonald, Kelly S ^b   Ball, T Blake ^e   Clerici, Mario ^c   Plummer, Francis A ^e  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MANITOBA   (Canada)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e NONE

Author keywords

Africa; Cellular immunity; Commercial sex workers; Genital tract; HIV 1 resistance; Humoral immunity; Sexual behaviour

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 2; VIRUS ENVELOPE PROTEIN;

ARTICLE; BEHAVIOR; ENZYME IMMUNOASSAY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE RESPONSE; INFECTION RESISTANCE; KENYA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTITUTION; QUESTIONNAIRE; UTERINE CERVIX MUCOSA; VAGINA MUCOSA;

CD4 LYMPHOCYTE COUNT; CERVIX UTERI; COHORT STUDIES; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, NATURAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; KENYA; MUCOUS MEMBRANE; PROSTITUTION; VAGINA;

EID: 0032989686     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199901140-00004     Document Type: Article

References (31)

1. 1. Shearer GM, Clerici M: Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today 1996, 17:21-24.
2. 2. Rowland-Jones S, Sutton J, Ariyoshi K, et al.: HIV-specific T-cells in HIV-exposed but uninfected Gambian women. Nature Med 1995, 1:59-64.
3. 3. Rowland-Jones SL, Dong T, Fowke KR, et al.: Cytotoxic T-cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998, 102:1758-1765.
4. 4. Pinto LA, Sullivan J, Berzofsky JA, et al.: Env-specific cytotoxic T-lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest 1995, 96:867-876.
5. 5. Langlade-Demoyen P, Ngo-Giang-Huong F, Ferchal F, Oksenhendler E: HIV-nef-specific cytotoxic T-lymphocytes in non-infected heterosexual contacts of HIV infected patients. J Clin Invest 1994, 93:1293-1297.
6. 6. Clerici M, Giorgi GV, Chou CC, et al.: Cell mediated immune response to human immunodeficiency virus type 1 (HIV-1) in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis 1992, 165:1012-1019.
7. 7. Barcellini W, Rizzardi GP, Velati C, et al.: In vitro production of type I and type II cytokines by peripheral blood mononuclear cells from high-risk HIV-negative intravenous drug users. AIDS 1995, 9:691-694.
8. 8. Rowland-Jones SL, Nixon DF, Aldous MC, et al.: HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant, Lancet 1993, 341:860-861.
9. 9. Paxton WA, Martin SR, Tse D, et al.: Relative resistance to HIV-1 infection in CD4 lympocytes from perons who remain uninfected despite multiple high-risk sexual exposures. Nature Med 1996, 3:412-417.
10. 10. Liu R, Paxton WA, Choe S, et al.: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86:367-377.
11. 11. World Health Organisation: AIDS 4, Global Data. Weekly Epidemiol Rec. 1995, 70:5-12.
12. 12. d'Cruz-Grote D: Prevention of HIV in developing countries. Lancet 1996, 348:1071-1074.
13. 13. Simonsen JN, Cameron DW, Gakinya MN, et al.: Human immunodeficiency virus infection among men with sexually transmitted diseases: experience from a centre in Africa. N Engl J Med 1988, 319:274-278.
14. 14. Musey L, Hu Yuxiang, Eckert L, et al.: HIV-1 induces cytotoxic T-lymphocytes in the cervix of infected women. J Exp Med 1997, 185:293-303.
15. 15. Artenstein AW, VanCott TC, Sitz KV, et al: Mucosal immune responses in four distinct compartments of women infected with HIV-1: a comparison by site and correlation with clinical information. J Infect Dis 1997, 175:265-271.
16. 16. Mazzoli S, Trabattoni D, Lo Caputo S, et al.: HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nature Med 1997, 3:1-8.
17. 17. Simonsen JN, Plummer FA, Ngugi EN, et al.: HIV infection among lower socioeconomic strata prostitutes in Nairobi. AIDS 1990, 4:139-144.
18. 18. Ngugi EN, Plummer FP, Simonsen JN, et al.: Prevention of HIV transmission in Africa: the effectiveness of condom promotion and health education among high risk prostitutes. Lancet 1988, ii:887-890.
19. 19. Fowke KR, Nagelkerke NJD, Kimani J, et al.: Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet. 1996, 348:1347-1351.
20. 20. Dunand VA, Luscher M, Wade JA, et al.: Certain MHC Class II DR allelles are associated with decreased susceptibility to HIV-1 infection. 1997 Keystone Symposia. AIDS Pathogenesis, Keystone, Colorado, April 1997 [abstract 117].
21. 21. McNicholl JM, Smith DK, Qari SK, Hodge T: Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele (32 CCR5). Emerg Infect Dis 1997, 3:261-271.
22. 22. Fowke KR, Dong T, Rowland-Jones SL, et al.: HIV-1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV-1 infection or enhanced β-chemokine production. AIDS Res Hum Retrovir 1998, 14:1521-1530.
23. 23. Dawood MR, Allan R, Fowke K, Embree J, Hammond JW: Development of oligonucleotide primers and probes against structural and regulatory genes of human immunodeficiency virus 1 (HIV-1) and their use for amplification of HIV-1 provirus by using polymerase chain reaction. J Clin Microbiol 1992, 30:2279-2283.
24. 24. Clerici M, Stocks NI, Zajac RA, et al.: IL-2 production permits detection of antigenic peptide recognotion by T helper lymphocytes from asymptomatic, HIV seropositive individuals. Nature 1989, 339:383-385.
25. 25. Plummer FA, Simonsen JN, Cameron DW, et al.: Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991,163:233-239.
26. 26. Duprat C, Mohammed Z, Datta P, et al.: Human immunodeficiency virus type 1 IgA antibody in the breast milk and serum. Pediatr Infect Dis J 1994, 13:603-608.
27. 27. Belec L, Georges AJ, Steenman G, Martin PMV: Antibodies to Human Immunodeficiency Virus in vaginal secretions of heterosexual women. J Infect Dis 1989, 160:385-391.
28. 28. Mulks MH, Plaut AG: IgA protease production as a characteristic distinguishing pathogenic from harmless neisseriaceae. New Engl J Med 1978, 299:973-976.
29. 29. Reinholdt J, Kilian M: Comparative analysis of immunoglobulin A1 protease activity among bacteria representing different genera, species and strains. Infect Immunol 1997, 65:4452-4459.
30. 30. Kilian M, Reinholdt J, Lumholt H, Poulsen K, Frandsen EV: Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. APMIS 1996, 104:321-338.
31. 31. McElrath MJ, Siliciano RF, Weinhold KJ: HIV type I vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization and quantitation. AIDS Res Hum Retrovirol 1997, 13:211-216.